These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29588716)

  • 21. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study.
    Rittger H; Brachmann J; Sinha AM; Waliszewski M; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Breithardt OA; Schmidt M; Zimmermann S; Lonke S; von Cranach M; Nguyen TV; Daniel WG; Wöhrle J
    J Am Coll Cardiol; 2012 Apr; 59(15):1377-82. PubMed ID: 22386286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial.
    Rissanen TT; Uskela S; Eränen J; Mäntylä P; Olli A; Romppanen H; Siljander A; Pietilä M; Minkkinen MJ; Tervo J; Kärkkäinen JM;
    Lancet; 2019 Jul; 394(10194):230-239. PubMed ID: 31204115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2.
    Gilgen N; Farah A; Scheller B; Ohlow MA; Mangner N; Weilenmann D; Wöhrle J; Jamshidi P; Leibundgut G; Möbius-Winkler S; Zweiker R; Krackhardt F; Butter C; Bruch L; Kaiser C; Hoffmann A; Rickenbacher P; Mueller C; Stephan FP; Coslovsky M; Jeger R;
    Clin Cardiol; 2018 May; 41(5):569-575. PubMed ID: 29527709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease.
    Nishiyama N; Komatsu T; Kuroyanagi T; Fujikake A; Komatsu S; Nakamura H; Yamada K; Nakahara S; Kobayashi S; Taguchi I
    Int J Cardiol; 2016 Nov; 222():113-118. PubMed ID: 27494722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rotational Atherectomy Combined with Drug Coated-Balloons for in-Stent Restenosis.
    Allan M; Vickers D; Pitney M; Jepson N
    Cardiovasc Revasc Med; 2019 Jul; 20(7):559-562. PubMed ID: 30217627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is Coronary Brachytherapy Staging a Comeback for the Treatment of In-Stent Restenosis?
    Kyaw H; Johal G; Gedela M; Barman N; Kini A; Sharma SK
    Curr Cardiol Rep; 2021 Oct; 23(11):156. PubMed ID: 34599432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
    Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
    EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
    Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evolution and revolution of drug coated balloons in coronary angioplasty: An up-to-date review of literature data.
    Cortese B; Kalkat H; Bathia G; Basavarajaiah S
    Catheter Cardiovasc Interv; 2023 Nov; 102(6):1069-1077. PubMed ID: 37870079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.
    Poerner TC; Duderstadt C; Goebel B; Kretzschmar D; Figulla HR; Otto S
    Clin Res Cardiol; 2017 Jan; 106(1):18-27. PubMed ID: 27379610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multicenter results of coronary implantation of balloon expandable Palmaz-Schatz vascular stents].
    Haude M; Erbel R; Hafner G; Heublein B; Hoepp HW; Franzen D; Prellwitz W; Lichtlen P; Hilger HH; Meyer J
    Z Kardiol; 1993 Feb; 82(2):77-86. PubMed ID: 8465569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and Efficacy of a Hybrid Approach Combining a Paclitaxel-Coated Balloon With a New Generation Drug-Eluting Stent in Patients With De Novo True Coronary Bifurcation Lesions.
    Kasbaoui S; Payot L; Zabalawi A; Delaunay R; Amara WB; Boukhris M; Taldir G
    Cardiovasc Revasc Med; 2023 Sep; 54():47-56. PubMed ID: 37150642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous coronary intervention: balloons, stents and scaffolds.
    Colleran R; Kastrati A
    Clin Res Cardiol; 2018 Aug; 107(Suppl 2):55-63. PubMed ID: 30039189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
    Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
    JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of paclitaxel-coated balloon angioplasty and paclitaxel-eluting stent implantation for treatment of coronary in-stent restenosis in patients with stable coronary artery disease.
    Bonaventura K; Leber AW; Sohns C; Roser M; Boldt LH; Kleber FX; Haverkamp W; Dorenkamp M
    Clin Res Cardiol; 2012 Jul; 101(7):573-84. PubMed ID: 22350752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of a drug-eluting balloon first and then bare metal stent with a drug-eluting stent for treatment of de novo lesions: study protocol of a randomized controlled trial.
    Park SD; Yoon CH; Oh IY; Suh JW; Cho YS; Youn TJ; Choi DJ; Chae IH
    Trials; 2013 Feb; 14():38. PubMed ID: 23394404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial.
    Greco A; Sciahbasi A; Abizaid A; Mehran R; Rigattieri S; de la Torre Hernandez JM; Alfonso F; Cortese B
    Catheter Cardiovasc Interv; 2022 Oct; 100(4):544-552. PubMed ID: 36054266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First-in-man 1-year clinical outcomes of the Catania Coronary Stent System with Nanothin Polyzene-F in de novo native coronary artery lesions: the ATLANTA (Assessment of The LAtest Non-Thrombogenic Angioplasty stent) trial.
    Tamburino C; La Manna A; Di Salvo ME; Sacchetta G; Capodanno D; Mehran R; Dangas G; Corcos T; Prati F
    JACC Cardiovasc Interv; 2009 Mar; 2(3):197-204. PubMed ID: 19463426
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.